{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:33:38Z","timestamp":1785522818728,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2025M771976"],"award-info":[{"award-number":["2025M771976"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key Research and Development Program of China","award":["2021YFA1201200"],"award-info":[{"award-number":["2021YFA1201200"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation","doi-asserted-by":"crossref","award":["52273153"],"award-info":[{"award-number":["52273153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hangzhou Agriculture and Social Development Research Project","award":["202004A12"],"award-info":[{"award-number":["202004A12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04528-6","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:47:11Z","timestamp":1784692031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mucus and tumor penetrating paclitaxel micelles for potent local therapy of cervical cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Yijie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangla","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianguo","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1837-7976","authenticated-orcid":false,"given":"Youqing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6240-0857","authenticated-orcid":false,"given":"Nasha","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"3","key":"4528_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"key":"4528_CR2","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024; CA Cancer J Clin. 2024;74(1):12\u201349.","DOI":"10.3322\/caac.21820"},{"issue":"8","key":"4528_CR3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S1470-2045(24)00274-2","volume":"25","author":"SS Murthy","year":"2024","unstructured":"Murthy SS, Trapani D, Cao B, Bray F, Murthy S, Kingham TP, Are C, Ilbawi AM. Premature mortality trends in 183 countries by cancer type, sex, WHO region, and World Bank income level in 2000-19: a retrospective, cross-sectional, population-based study. Lancet Oncol. 2024;25(8):969\u201378.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4528_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s44178-025-00200-5","volume":"4","author":"X Zhang","year":"2025","unstructured":"Zhang X, Lou H. Review of radiotherapy for cervical cancer. Holist Integr Oncol. 2025;4(1):64.","journal-title":"Holist Integr Oncol"},{"issue":"3","key":"4528_CR5","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1016\/S1470-2045(24)00524-2","volume":"26","author":"M Kyrgiou","year":"2025","unstructured":"Kyrgiou M, Bowden SJ, Ellis LB, Hammer A, Lyons D, Freeman-Wang T, Kechagias KS, Kalliala I, Preti M, Kesic V, Zapardiel I, Cruickshank M, Gultekin M, Martin-Hirsch P. Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement. Lancet Oncol. 2025;26(3):e140\u201351.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4528_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12916-025-03975-6","volume":"23","author":"S Han","year":"2025","unstructured":"Han S, Lin M, Liu M, Wu S, Guo P, Guo J, Xie L, Qiu S, Xu A, Cai Y, Chen Y. Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases. BMC Med. 2025;23(1):158.","journal-title":"BMC Med"},{"issue":"1","key":"4528_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s44178-024-00113-9","volume":"4","author":"J Liu","year":"2025","unstructured":"Liu J, Kang Y, Li L, Zang L, Luo L, Zhu F, Zhu M, Zhang H, Xu Q. Efficacy and safety of immunotherapy in cervical cancer: a review of advances in immune-related therapy for cervical cancer. Holist Integr Oncol. 2025;4(1):15.","journal-title":"Holist Integr Oncol"},{"issue":"3","key":"4528_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41571-024-00977-w","volume":"22","author":"AA Francoeur","year":"2025","unstructured":"Francoeur AA, Monk BJ, Tewari KS. Treatment advances across the cervical cancer spectrum. Nat Rev Clin Oncol. 2025;22(3):182\u201399.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"4528_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1200\/JGO.2016.003954","volume":"2","author":"LT Chuang","year":"2016","unstructured":"Chuang LT, Temin S, Camacho R, Due\u00f1as-Gonzalez A, Feldman S, Gultekin M, Gupta V, Horton S, Jacob G, Kidd EA, Lishimpi K, Nakisige C, Nam JH, Ngan HYS, Small W, Thomas G, Berek JS. Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline. J global Oncol. 2016;2(5):311\u201340.","journal-title":"J global Oncol"},{"key":"4528_CR10","doi-asserted-by":"crossref","unstructured":"Das T, Anand U, Pandey SK, Ashby CR Jr., Assaraf YG, Chen ZS, Dey A. Therapeutic strategies to overcome taxane resistance in cancer. Drug Resistance Updates. 2021;55:100754.","DOI":"10.1016\/j.drup.2021.100754"},{"issue":"10462","key":"4528_CR11","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","volume":"404","author":"M McCormack","year":"2024","unstructured":"McCormack M, Eminowicz G, Gallardo D, Diez P, Farrelly L, Kent C, Hudson E, Panades M, Mathew T, Anand A, Persic M, Forrest J, Bhana R, Reed N, Drake A, Adusumalli M, Mukhopadhyay A, King M, Whitmarsh K, McGrane J, Colombo N, Mak C, Mandal R, Chowdhury RR, Alamilla-Garcia G, Ch\u00e1vez-Blanco A, Stobart H, Feeney A, Vaja S, Hacker AM, Hackshaw A, Ledermann JA. Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial. Lancet. 2024;404(10462):1525\u201335.","journal-title":"Lancet"},{"key":"4528_CR12","doi-asserted-by":"crossref","unstructured":"Mosca L, Ilari A, Fazi F, Assaraf Y. G., Colotti G. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming. Drug Resist Updates. 2021;54:100742.","DOI":"10.1016\/j.drup.2020.100742"},{"issue":"10421","key":"4528_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(23)02405-4","volume":"403","author":"A Oaknin","year":"2024","unstructured":"Oaknin A, Gladieff L, Mart\u00ednez-Garc\u00eda J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fari\u00f1as-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarc\u00f3n J, Follana P, Romero I, Lebreton C, P\u00e9rez-Fidalgo JA, Yunokawa M, Dahlstrand H, D\u2019Hondt V, Randall LM. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial. Lancet. 2024;403(10421):31\u201343.","journal-title":"Lancet"},{"key":"4528_CR14","doi-asserted-by":"crossref","unstructured":"Kalogera E, Nevala WK, Finnes HD, Suman VJ, Schimke JM, Strand CA, Kottschade LA, Kudgus RA, Buhrow SA, Becher LR, Geng L, Glaser GE, Grudem ME, Jatoi A, Klampe CM, Kumar A, Langstraat CL, McWilliams RR, Wahner Hendrickson AE, Weroha SJ, Yan Y, Reid JM, Markovic SN, Block MS. A Phase I Trial of Nab-Paclitaxel\/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clinical Cancer Res. 2024:30(12):2623\u201335.","DOI":"10.1158\/1078-0432.CCR-23-3196"},{"key":"4528_CR15","doi-asserted-by":"publisher","first-page":"120790","DOI":"10.1016\/j.biomaterials.2021.120790","volume":"272","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang W, Wang Y, Zhu J, Zhou M, Peng C, He Z, Sun J, Li Z, Gui S. Emerging nanotaxanes for cancer therapy. Biomaterials. 2021;272:120790.","journal-title":"Biomaterials"},{"key":"4528_CR16","doi-asserted-by":"crossref","unstructured":"Liu Y, Yang Z, Feng L, Xia Y, Wei G, Lu W. Advance in Nanomedicine for Improving Mucosal Penetration and Effective Therapy of Cervical Cancer. Small. 2024;20(41):e2303772.","DOI":"10.1002\/smll.202303772"},{"key":"4528_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jconrel.2024.06.020","volume":"371","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Bu F, Xu C, Wu T, Zhou J, Shen W, Yin T. A coordinative modular assembly-constructed self-reinforced nano-therapeutic agent for effective antitumor-immune activation. J Controlled Release. 2024;371:588\u2013602.","journal-title":"J Controlled Release"},{"key":"4528_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.addr.2021.04.009","volume":"174","author":"X Wang","year":"2021","unstructured":"Wang X, Liu S, Guan Y, Ding J, Ma C, Xie Z. Vaginal drug delivery approaches for localized management of cervical cancer. Adv Drug Deliv Rev. 2021;174:114\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"4528_CR19","doi-asserted-by":"crossref","unstructured":"Qian Q, Shi L, Gao X, Ma Y, Yang J, Zhang Z, Qian J, Zhu X. A Paclitaxel-Based Mucoadhesive Nanogel with Multivalent Interactions for Cervical Cancer Therapy. Small. 2019;15(47):e1903208.","DOI":"10.1002\/smll.201903208"},{"issue":"6","key":"4528_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/polym16060775","volume":"16","author":"R AlAnsari","year":"2024","unstructured":"AlAnsari R, Hasan B, Deen GR, Torsten U. Hydrogel- and Nanocomposite-Based Drug-Delivery Strategies in the Treatment of Vaginal Infections. Polymers. 2024;16(6):775.","journal-title":"Polymers"},{"issue":"6","key":"4528_CR21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/pharmaceutics13060884","volume":"13","author":"T Osma\u0142ek","year":"2021","unstructured":"Osma\u0142ek T, Froelich A, Jadach B, Tatarek A, Gadzi\u0144ski P, Falana A, Grali\u0144ska K, Ekert M, Puri V, Wroty\u0144ska-Barczy\u0144ska J, Michniak-Kohn B. Recent Advances in Polymer-Based Vaginal Drug Delivery Systems. Pharmaceutics. 2021;13(6):884.","journal-title":"Pharmaceutics"},{"key":"4528_CR22","doi-asserted-by":"publisher","first-page":"114543","DOI":"10.1016\/j.addr.2022.114543","volume":"191","author":"RL Shapiro","year":"2022","unstructured":"Shapiro RL, DeLong K, Zulfiqar F, Carter D, Better M, Ensign LM. In vitro and ex vivo models for evaluating vaginal drug delivery systems. Adv Drug Deliv Rev. 2022;191:114543.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"4528_CR23","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/polym15071615","volume":"15","author":"N Vasquez-Mart\u00ednez","year":"2023","unstructured":"Vasquez-Mart\u00ednez N, Guillen D, Moreno-Mendieta SA, Sanchez S, Rodr\u00edguez-Sanoja R. The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants. Polymers. 2023;15(7):1615.","journal-title":"Polymers"},{"issue":"8","key":"4528_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/17425247.2019.1645117","volume":"16","author":"S Rossi","year":"2019","unstructured":"Rossi S, Vigani B, Sandri G, Bonferoni MC, Caramella CM, Ferrari F. Recent advances in the mucus-interacting approach for vaginal drug delivery: from mucoadhesive to mucus-penetrating nanoparticles. Expert Opin Drug Deliv. 2019;16(8):777\u201381.","journal-title":"Expert Opin Drug Deliv"},{"issue":"16","key":"4528_CR25","doi-asserted-by":"publisher","first-page":"e2109189","DOI":"10.1002\/adma.202109189","volume":"34","author":"W Fan","year":"2022","unstructured":"Fan W, Wei Q, Xiang J, Tang Y, Zhou Q, Geng Y, Liu Y, Sun R, Xu L, Wang G, Piao Y, Shao S, Zhou Z, Tang J, Xie T, Li Z, Shen Y. Mucus Penetrating and Cell-Binding Polyzwitterionic Micelles as Potent Oral Nanomedicine for Cancer Drug Delivery. Adv Mater. 2022;34(16):e2109189.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"issue":"18","key":"4528_CR26","doi-asserted-by":"publisher","first-page":"10920","DOI":"10.1021\/acs.chemrev.3c00062","volume":"123","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Xiang J, Qiu N, Wang Y, Piao Y, Shao S, Tang J, Zhou Z, Shen Y. Tumor Abnormality-Oriented Nanomedicine Design. Chem Rev. 2023;123(18):10920\u201389.","journal-title":"Chem Rev"},{"issue":"9","key":"4528_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s44222-025-00321-6","volume":"3","author":"Y Chen","year":"2025","unstructured":"Chen Y, Su Y-C, Roffler SR. Polyethylene glycol immunogenicity in nanomedicine. Nat Reviews Bioeng. 2025;3(9):742\u201360.","journal-title":"Nat Reviews Bioeng"},{"key":"4528_CR28","doi-asserted-by":"publisher","first-page":"12263","DOI":"10.2147\/IJN.S535644","volume":"20","author":"R Zhao","year":"2025","unstructured":"Zhao R, Liu Z, Fan L, Fu M, Wu Y. Advances in Nanotechnology in the Diagnosis and Treatment of Gynecological Cancers. Int J Nanomed. 2025;20:12263\u201381.","journal-title":"Int J Nanomed"},{"issue":"11","key":"4528_CR29","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/s41563-025-02381-w","volume":"24","author":"W Gao","year":"2025","unstructured":"Gao W, Zhang L. Making way for PEG alternatives. Nat Mater. 2025;24(11):1682\u20133.","journal-title":"Nat Mater"},{"issue":"8093","key":"4528_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-025-09729-x","volume":"648","author":"Q Wei","year":"2025","unstructured":"Wei Q, He Z, Li Z, Zhou Z, Piao Y, Huang J, Geng Y, Zhang R, Fu Y, Ye J, Yuan Y, Zhu H, Zeng J, Zhang Y, Zhou Q, Xu M, Shao S, Tang J, Xiang J, Chen R, Zhou R, Shen Y. A skin-permeable polymer for non-invasive transdermal insulin delivery. Nature. 2025;648(8093):459\u201367.","journal-title":"Nature"},{"issue":"2","key":"4528_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.7150\/thno.39167","volume":"10","author":"X Ji","year":"2020","unstructured":"Ji X, Yuan X, Ma L, Bi B, Zhu H, Lei Z, Liu W, Pu H, Jiang J, Jiang X, Zhang Y, Xiao J. Mesenchymal stem cell-loaded thermosensitive hydroxypropyl chitin hydrogel combined with a three-dimensional-printed poly(\u03b5-caprolactone) \/nano-hydroxyapatite scaffold to repair bone defects via osteogenesis, angiogenesis and immunomodulation. Theranostics. 2020;10(2):725\u201340.","journal-title":"Theranostics"},{"issue":"5","key":"4528_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2174\/138161282005140214165212","volume":"20","author":"YH Choi","year":"2014","unstructured":"Choi YH, Yu AM. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Curr Pharm Design. 2014;20(5):793\u2013807.","journal-title":"Curr Pharm Design"},{"issue":"2","key":"4528_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G, Migliaccio A. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52(2):192\u2013203.","journal-title":"Exp Mol Med"},{"issue":"12","key":"4528_CR34","doi-asserted-by":"publisher","first-page":"e2200173","DOI":"10.1002\/advs.202200173","volume":"9","author":"J Xiang","year":"2022","unstructured":"Xiang J, Shen Y, Zhang Y, Liu X, Zhou Q, Zhou Z, Tang J, Shao S, Shen Y. Multipotent Poly(Tertiary Amine-Oxide) Micelles for Efficient Cancer Drug Delivery. Adv Sci. 2022;9(12):e2200173.","journal-title":"Adv Sci"},{"issue":"34","key":"4528_CR35","doi-asserted-by":"publisher","first-page":"10631","DOI":"10.1021\/acs.nanolett.4c02978","volume":"24","author":"J Zhou","year":"2024","unstructured":"Zhou J, Shen W, Feng W, Zhang X, Wu T, Zhou J, Su Z, Yin T. Temperature Self-Limited Intelligent Thermo-chemotherapeutic Lipid Nanosystem for P-gp Reversal Time Window Matched Pulse Treatment of MDR Tumor. Nano Lett. 2024;24(34):10631\u201341.","journal-title":"Nano Lett"},{"key":"4528_CR36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jconrel.2021.07.008","volume":"336","author":"F Lv","year":"2021","unstructured":"Lv F, Wang J, Chen H, Sui L, Feng L, Liu Z, Liu Y, Wei G, Lu W. Enhanced mucosal penetration and efficient inhibition efficacy against cervical cancer of PEGylated docetaxel nanocrystals by TAT modification. J Controlled Release. 2021;336:572\u201382.","journal-title":"J Controlled Release"},{"key":"4528_CR37","doi-asserted-by":"crossref","unstructured":"Choi J, Park B, Park JY, Shin D, Lee S, Yoon HY, Kim K, Kim SH, Kim Y, Yang Y, Shim MK. Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy. Adv Mater. 2024;36(38):e2405475.","DOI":"10.1002\/adma.202405475"},{"key":"4528_CR38","doi-asserted-by":"publisher","first-page":"11847","DOI":"10.2147\/IJN.S490400","volume":"19","author":"YC Zhao","year":"2024","unstructured":"Zhao YC, Li X, Wang CQ, Jiao Y, Shen YN, Wang TJ, Zhang CH. Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database. Int J Nanomed. 2024;19:11847\u201358.","journal-title":"Int J Nanomed"},{"key":"4528_CR39","doi-asserted-by":"crossref","unstructured":"Zhang J, Pan Y, Shi Q, Zhang G, Jiang L, Dong X, Gu K, Wang H, Zhang X, Yang N, Li Y, Xiong J, Yi T, Peng M, Song Y, Fan Y, Cui J, Chen G, Tan W, Zang A, Guo Q, Zhao G, Wang Z, He J, Yao W, Wu X, Chen K, Hu X, Hu C, Yue L, Jiang D, Wang G, Liu J, Yu G, Li J, Bai J, Xie W, Zhao W, Wu L, Zhou C. Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study. Cancer Commun. 2022;42(1):3\u201316.","DOI":"10.1002\/cac2.12225"},{"issue":"26","key":"4528_CR40","doi-asserted-by":"publisher","first-page":"16516","DOI":"10.1021\/acsnano.3c12537","volume":"18","author":"C Chargari","year":"2024","unstructured":"Chargari C, Maury P, Texier M, Genestie C, Morice P, Bockel S, Gouy S, Ba M, Achkar S, Lux F, Tillement O, Dufort S, Duc GLE, Debeaumont O, Massard C, Maulard A, Porcel E, Bahleda R, Ammari S, Morel D, Espenel S, Pautier P, Robert C, Deutsch E. Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer. ACS Nano. 2024;18(26):16516\u201329.","journal-title":"ACS Nano"},{"issue":"7","key":"4528_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1208\/s12249-025-03205-5","volume":"26","author":"NM Sheta","year":"2025","unstructured":"Sheta NM, Shamma RN, Hussein RRS, Salem SAM, Abdelaty LN, El Abd MM, Abdel-Haleem KM. Voriconazole Loaded Spanlastics: Design, Formulation, Optimization, and Randomized Controlled Clinical Insights for Vulvovaginal Candidiasis Therapy. AAPS PharmSciTech. 2025;26(7):219.","journal-title":"AAPS PharmSciTech"},{"key":"4528_CR42","doi-asserted-by":"publisher","first-page":"119902","DOI":"10.1016\/j.biomaterials.2020.119902","volume":"240","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Dong C, Fan W, Jiang H, Xiang J, Qiu N, Piao Y, Xie T, Luo Y, Li Z, Liu F, Shen Y. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy. Biomaterials. 2020;240:119902.","journal-title":"Biomaterials"},{"issue":"9","key":"4528_CR43","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41551-021-00701-4","volume":"5","author":"S Chen","year":"2021","unstructured":"Chen S, Zhong Y, Fan W, Xiang J, Wang G, Zhou Q, Wang J, Geng Y, Sun R, Zhang Z, Piao Y, Wang J, Zhuo J, Cong H, Jiang H, Ling J, Li Z, Yang D, Yao X, Xu X, Zhou Z, Tang J, Shen Y. Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion-drug conjugates with cell-membrane affinity. Nat biomedical Eng. 2021;5(9):1019\u201337.","journal-title":"Nat biomedical Eng"},{"issue":"1","key":"4528_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/adma.201404059","volume":"27","author":"Q Shao","year":"2015","unstructured":"Shao Q, Jiang S. Molecular understanding and design of zwitterionic materials. Adv Mater. 2015;27(1):15\u201326.","journal-title":"Adv Mater"},{"issue":"67","key":"4528_CR45","doi-asserted-by":"publisher","first-page":"10015","DOI":"10.1039\/C9CC04291A","volume":"55","author":"Y Geng","year":"2019","unstructured":"Geng Y, Zhong Y, Zhou Q, Chen S, Piao Y, Yin W, Lu H, Shen Y. A neutral water-soluble mitochondria-targeting polymer. Chem Commun (Camb Engl). 2019;55(67):10015\u20138.","journal-title":"Chem Commun (Camb Engl)"},{"issue":"4","key":"4528_CR46","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1021\/acsnano.0c00708","volume":"14","author":"Z Yu","year":"2020","unstructured":"Yu Z, Guo J, Hu M, Gao Y, Huang L. Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma. ACS Nano. 2020;14(4):4816\u201328.","journal-title":"ACS Nano"},{"issue":"4","key":"4528_CR47","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/pharmaceutics12040371","volume":"12","author":"D Manzanares","year":"2020","unstructured":"Manzanares D, Ce\u00f1a V, Endocytosis. The Nanoparticle and Submicron Nanocompounds Gateway into the Cell. Pharmaceutics. 2020;12(4):371.","journal-title":"Pharmaceutics"},{"issue":"8","key":"4528_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","volume":"14","author":"Q Zhou","year":"2019","unstructured":"Zhou Q, Shao S, Wang J, Xu C, Xiang J, Piao Y, Zhou Z, Yu Q, Tang J, Liu X, Gan Z, Mo R, Gu Z, Shen Y. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy. Nat Nanotechnol. 2019;14(8):799\u2013809.","journal-title":"Nat Nanotechnol"},{"key":"4528_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.bioactmat.2023.10.017","volume":"32","author":"X Shen","year":"2024","unstructured":"Shen X, Pan D, Gong Q, Gu Z, Luo K. Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives. Bioactive Mater. 2024;32:445\u201372.","journal-title":"Bioactive Mater"},{"issue":"11","key":"4528_CR50","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/s41563-025-02383-8","volume":"24","author":"N Chaudhary","year":"2025","unstructured":"Chaudhary N, Whitehead KA. Designing around immune memory to counter PEG immunogenicity. Nat Mater. 2025;24(11):1666\u20139.","journal-title":"Nat Mater"},{"issue":"45","key":"4528_CR51","doi-asserted-by":"publisher","first-page":"7615","DOI":"10.1002\/adma.201401554","volume":"26","author":"Q Sun","year":"2014","unstructured":"Sun Q, Sun X, Ma X, Zhou Z, Jin E, Zhang B, Shen Y, Van Kirk EA, Murdoch WJ, Lott JR, Lodge TP, Radosz M, Zhao Y. Integration of nanoassembly functions for an effective delivery cascade for cancer drugs. Adv Mater. 2014;26(45):7615\u201321.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"issue":"3","key":"4528_CR52","doi-asserted-by":"publisher","first-page":"100037","DOI":"10.1016\/j.preme.2025.100037","volume":"2","author":"J Zheng","year":"2025","unstructured":"Zheng J, Sun Y, Shen Y, Zhou Z. Surface engineering of nanoparticles for precision medicine. Precision Med Eng. 2025;2(3):100037.","journal-title":"Precision Med Eng"},{"issue":"16","key":"4528_CR53","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2217\/nnm-2020-0035","volume":"15","author":"T Garanti","year":"2020","unstructured":"Garanti T, Alhnan MA, Wan KW. RGD-decorated solid lipid nanoparticles enhance tumor targeting, penetration and anticancer effect of asiatic acid. Nanomed. 2020;15(16):1567\u201383.","journal-title":"Nanomed"},{"issue":"1","key":"4528_CR54","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.actbio.2021.10.034","volume":"16","author":"Q Huang","year":"2021","unstructured":"Huang Q, Li X, Wang H, Liu X, Zhang Q, Li K, Chen Y. Qian Zhu,Youqing Shen, Meihua Sui. A nanotherapeutic strategy to overcomechemoresistance to irinotecan\/7-ethyl-10-hydroxy-camptothecin in colorectalcancer. Acta Biomater. 2021;16(1):104\u201313. https:\/\/doi.org\/10.1016\/j.actbio.2021.10.034","journal-title":"Acta Biomater"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04528-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04528-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04528-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:19:35Z","timestamp":1785518375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04528-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4528"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04528-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"700"}}